bms204352 has been researched along with epirubicin in 2 studies
Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (epirubicin) | Trials (epirubicin) | Recent Studies (post-2010) (epirubicin) |
---|---|---|---|---|---|
49 | 1 | 12 | 5,453 | 1,838 | 1,570 |
Protein | Taxonomy | bms204352 (IC50) | epirubicin (IC50) |
---|---|---|---|
Genome polyprotein | 0.75 | ||
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.181 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 review(s) available for bms204352 and epirubicin
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
1 other study(ies) available for bms204352 and epirubicin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |